Jin Tae Kim

Jin Tae Kim

Auto-generated profile, based on publicly available information

Jin Tae Kim

Department of Food Science and Biotechnology, Chung-Ang University, Anseong, Republic of Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2018 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
JCJing Chen
Jing Chen
CBCheng Bao
Cheng Bao
JKJin Tae Kim
Jin Tae Kim
JCJae Seok Cho
Jae Seok Cho
SQShuai Qiu
Shuai Qiu
Hong Jin LeeHong Jin Lee
Hong Jin Lee

1 December 2020 in Phytomedicine
Verified
Journal Article
Closed access
JCJing Chen
Jing Chen
SQShuai Qiu
Shuai Qiu
JKJin Tae Kim
Jin Tae Kim
JCJae Seok Cho
Jae Seok Cho
JMJi Hyun Moon
Ji Hyun Moon
Hong Jin LeeHong Jin Lee
Hong Jin Lee

1 October 2019 in Journal of Functional Foods
Verified
Journal Article
Closed access
CBCheng Bao
Cheng Bao
JCJing Chen
Jing Chen
JKJin Tae Kim
Jin Tae Kim
SQShuai Qiu
Shuai Qiu
JCJae Seok Cho
Jae Seok Cho
Hong Jin LeeHong Jin Lee
Hong Jin Lee

9 April 2019 in Food & Function
Verified
Journal Article
Closed access
PDF file
JCJing Chen
Jing Chen
JKJiwon Ko
Jiwon Ko
JKJin Tae Kim
Jin Tae Kim
JCJae Seok Cho
Jae Seok Cho
SQShuai Qiu
Shuai Qiu
Hong Jin LeeHong Jin Lee
Hong Jin Lee
β-Thujaplicin, a natural monoterpenoid, has been demonstrated to exert health beneficial activities in chronic diseases. However, it has not been studied in regulating estrogen receptor (ER) negative breast cancer. Here, we investigated the effect of β-thujaplicin on inhibiting ER-negative basal-like breast cancer and the underlying mechanism of action using an in vitro and in vivo xenograft animal model. β-Thujaplicin induced G0/G1 phase cell cycle arrest and regulated cell cycle mediators, cyclin D1, cyclin E, and cyclin-dependent kinase 4 (CDK 4), leading to the inhibition of the proliferation of ER-negative basal-like MCF10DCIS.com human breast cancer cells. It also modulated the phosphorylation of protein kinase B (AKT) and glycogen synthase kinase (GSK-3β) and the protein level of β-catenin. In an MCF10DCIS.com xenograft animal model, β-thujaplicin significantly inhibited tumor growth, reduced tumor weight, and regulated the expression of cell cycle proteins, phosphorylation of AKT and GSK-3β, and protein level of β-catenin in the tumor tissues. These results demonstrate that β-thujaplicin can suppress basal-like mammary tumor growth by regulating GSK-3β/β-catenin signaling, suggesting that β-thujaplicin may be a potent chemopreventive agent against the basal-like subtype of breast cancer.

16 August 2024 in Food Science and Biotechnology
Verified
Journal Article
Closed access
PDF file
JKJin Tae Kim
Jin Tae Kim
DJDong Hyeon Jeon
Dong Hyeon Jeon
Hong Jin LeeHong Jin Lee
Hong Jin Lee

16 July 2022 in Food Science and Biotechnology
Verified
Journal Article
Closed access
PDF file
YZYimeng Zhou
Yimeng Zhou
JKJin Tae Kim
Jin Tae Kim
SQShuai Qiu
Shuai Qiu
SLSeung Beom Lee
Seung Beom Lee
HPHo Jin Park
Ho Jin Park
Hong Jin LeeHong Jin Lee
Hong Jin Lee